Authors
Benjamin R Lewis, Eric L Garland
Published in
Journal of psychopharmacology (Oxford, England). Pages 2698811261495546. Nov 05, 2026. Epub Nov 05, 2026.
Abstract
Relapse in opioid use disorder (OUD) remains common despite pharmacotherapy. Altered interoceptive processing may contribute to addiction, and ketamine-induced changes in salience and insula-related networks may facilitate mindfulness-based interoceptive learning.
This secondary analysis examined whether ketamine-assisted psychotherapy (KAP) added to Mindfulness-Oriented Recovery Enhancement (MORE) improved interoceptive awareness and whether these changes mediated reductions in opioid craving.
Sixty-eight adults with OUD receiving buprenorphine were randomized to 8 weeks of MORE with or without KAP. Assignment was unblinded, and outcomes were self-reported. Interoception was assessed using ecological momentary assessment (EMA) of body awareness and Multidimensional Assessment of Interoceptive Awareness (MAIA) subscales. Posttreatment EMA data were available for 18 MORE + KAP and 15 MORE participants. Mixed-effects models and path analysis were conducted.
Piecewise modeling showed a greater increase in EMA-assessed body awareness salience in MORE + KAP during days 1-35, spanning the pre-dosing and first-ketamine-dose period (B = 0.039, standard error (SE) = 0.005, p < 0.001). Slopes attenuated during days 36-90 (group × slope-change: B = -0.035, SE = 0.008, p < 0.001), although body awareness remained higher for MORE+KAP through follow-up. MORE + KAP increased MAIA Self-Regulation and Body Listening. A composite of these facets mediated reduced opioid craving at 3 months (indirect effect: B = -11.27, 95% bootstrap confidence interval (CI) [-25.50, -0.25], p = 0.044; κ2 = 0.378).
Adjunctive ketamine was associated with rapid, sustained increases in body awareness salience. Improvements in interoceptive regulatory capacity mediated reduced opioid craving, supporting interoception as a potential mechanism and treatment target in ketamine-augmented mindfulness interventions for OUD.
gov:NCT04892251.
PMID:
42989695
Bibliographic data and abstract were imported from PubMed on 06 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 33
- Comments 0